Logo image of MYSZ

MY SIZE INC (MYSZ) Stock Fundamental Analysis

NASDAQ:MYSZ - Nasdaq - US62844N4060 - Common Stock - Currency: USD

2  -0.05 (-2.44%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MYSZ. MYSZ was compared to 284 industry peers in the Software industry. MYSZ has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, MYSZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MYSZ had negative earnings in the past year.
MYSZ had a negative operating cash flow in the past year.
In the past 5 years MYSZ always reported negative net income.
MYSZ had a negative operating cash flow in each of the past 5 years.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

MYSZ has a Return On Assets of -65.17%. This is amonst the worse of the industry: MYSZ underperforms 87.73% of its industry peers.
MYSZ has a worse Return On Equity (-102.80%) than 76.90% of its industry peers.
Industry RankSector Rank
ROA -65.17%
ROE -102.8%
ROIC N/A
ROA(3y)-80.05%
ROA(5y)-119.73%
ROE(3y)-138.28%
ROE(5y)-246.89%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 400 -400 600

1.3 Margins

Looking at the Gross Margin, with a value of 43.96%, MYSZ is doing worse than 75.09% of the companies in the same industry.
In the last couple of years the Gross Margin of MYSZ has declined.
MYSZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.57%
GM growth 5YN/A
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

3

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYSZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MYSZ has been increased compared to 5 years ago.
MYSZ has a better debt/assets ratio than last year.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100K 200K 300K 400K
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -11.66, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -11.66, MYSZ is not doing good in the industry: 91.34% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.07 indicates that MYSZ is not too dependend on debt financing.
MYSZ has a Debt to Equity ratio (0.07) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -11.66
ROIC/WACCN/A
WACC8.57%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 2.49 indicates that MYSZ has no problem at all paying its short term obligations.
The Current ratio of MYSZ (2.49) is better than 68.95% of its industry peers.
A Quick Ratio of 1.56 indicates that MYSZ should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.56, MYSZ perfoms like the industry average, outperforming 46.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.56
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.07% over the past year.
MYSZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.89%.
Measured over the past years, MYSZ shows a very strong growth in Revenue. The Revenue has been growing by 266.60% on average per year.
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.56%
Revenue 1Y (TTM)43.89%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-14.7%

3.2 Future

The Earnings Per Share is expected to grow by 37.25% on average over the next years. This is a very strong growth
Based on estimates for the next years, MYSZ will show a quite strong growth in Revenue. The Revenue will grow by 16.77% on average per year.
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.
Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as MYSZ's earnings are expected to grow with 37.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MYSZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MY SIZE INC

NASDAQ:MYSZ (2/5/2025, 4:43:48 PM)

2

-0.05 (-2.44%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners4.34%
Inst Owner Change0%
Ins Owners9.15%
Ins Owner Change-0.31%
Market Cap2.52M
Analysts82.86
Price Target3.06 (53%)
Short Float %6.38%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.7%
Min EPS beat(2)-61.76%
Max EPS beat(2)48.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.42%
Min Revenue beat(2)-9.85%
Max Revenue beat(2)-2.99%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)49.22%
EPS NY rev (1m)0%
EPS NY rev (3m)13.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)-23.68
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-2.96
FCFYN/A
OCF(TTM)-2.95
OCFYN/A
SpS7.64
BVpS3.54
TBVpS2.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.17%
ROE -102.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.96%
FCFM N/A
ROA(3y)-80.05%
ROA(5y)-119.73%
ROE(3y)-138.28%
ROE(5y)-246.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.57%
GM growth 5YN/A
F-Score5
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 1.56
Altman-Z -11.66
F-Score5
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)23.63%
Cap/Depr(5y)90.84%
Cap/Sales(3y)6.09%
Cap/Sales(5y)38.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.56%
EPS Next Y82.6%
EPS Next 2Y37.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.89%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%-14.7%
Revenue Next Year20.8%
Revenue Next 2Y16.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.45%
OCF growth 3YN/A
OCF growth 5YN/A